Back to Pediatrics
PediatricsvModifiedEvidence-Based

Modified Finnegan Neonatal Abstinence Score (NAS)

Stratifies severity of opioid withdrawal in neonates and guides pharmacologic treatment decisions

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
nas score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Modified Finnegan Neonatal Abstinence Score (NAS) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within pediatrics.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Sum of points from all assessed categories: CNS disturbances (cry, sleep, reflexes, tremors, tone, excoriation, jerks, convulsions), metabolic/vasomotor (sweating, fever, yawning, mottling), respiratory (flaring, rate, sneezing, stuffiness), and GI (feeding, vomiting, stools).

Clinical Pearls & Practice Notes

  • Score every 3-4 hours during hospitalization
  • Two consecutive scores ≥12 OR three consecutive scores ≥8 indicate need for pharmacologic treatment
  • Most commonly used tool for neonatal abstinence syndrome assessment
  • Modified version removes some items and adds irritability and failure to thrive
  • Goal of treatment is to stabilize symptomatic infants to allow feeding, sleeping, and weight gain
  • Requires trained healthcare providers familiar with neonatal assessment
  • Consider non-pharmacologic interventions first (swaddling, minimal stimulation, frequent small feeds)
  • Morphine or methadone are first-line pharmacologic treatments

Evidence & Literature Citations

  1. Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975;2(1-2):141-58.
  2. Jansson LM, Velez M, Harrow C. The opioid-exposed newborn: assessment and pharmacologic management. J Opioid Manag. 2009 Jan-Feb;5(1):47-55.
  3. Hudak ML, Tan RC; Committee on Drugs; Committee on Fetus and Newborn; American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics. 2012 Feb;129(2):e540-60. doi: 10.1542/peds.2011-3212.

Score Interpretation Ranges

No Treatment0 – 7 pts

Mild or no withdrawal symptoms

Monitor Closely8 – 11 pts

Moderate withdrawal symptoms

Treat12 – 50 pts

Severe withdrawal symptoms

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.